The global absorbable hemostat market is estimated to be valued at USD 3.24 Bn in 2026 and is expected to reach USD 5.31 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033. Absorbable hemostat is a significant market within the surgical and wound care sector and involves biodegradable products used to prevent blood loss during surgical procedures that get naturally absorbed by the body after the surgery is completed. This approach obviates post-operative retrieval, simplifies procedures and aids patient recovery. Gelatin, collagen, cellulose and synthetic polymers are used to make these hemostats, and differ from each other depending on their suitability in certain procedures.
Increasing surgical procedure numbers coupled with rising incidences of chronic diseases in patients necessitates surgery and geriatric populations further propel the growth of the absorbable hemostat market. Technological advancements in hemostats that often include combination hemostats with varying modes of actions to enhance their effectiveness in various procedures are a major driver for their enhanced use. Additionally, increased use of modern surgery equipment by surgeons to enhance the outcome of surgery in minimum time frames aids in augmenting the growth of the market.
Market Dynamics
The global absorbable hemostat market is fueled by the rising number of surgical procedures conducted globally, backed by the growing incidences of diseases such as cardiovascular disorders, cancer, trauma injuries and chronic disorders. The ever-increasing utilization of minimally invasive surgical procedures, ongoing technological development of hemostatic agents in the forms of flowable and combination hemostats further spur the growth of the market. In addition, rising health expenditure and growing infrastructure for healthcare in developing economies.
The market is constrained by the high cost of absorbable hemostats in comparison with the other traditional bleeding control products and by extensive and critical regulatory compliances required for new product launch. However, risks of negative responses on few patients and restrictions in reimbursement in certain region can impact the growth. Nevertheless, the opportunities for high-growth is in the development of newer hemostats, expansion to emerging markets with higher growth prospects and increased investment on innovative biomaterials and bioengineered products for better surgical outcomes
Key Features of the Study
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on ‘Absorbable Hemostat Market' - Global forecast to 2033
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients